how tirzepatide reduce weight for Loss Tirzepatide (Zepbound) - A New

People who combine healthy lifestyle changes like diet and exercise with GLP-1 medications will see the best results

Figure 5 The SURMOUNT-1 study was a clinical trial of 72 weeks performed in 2539 obese patients without T2D that were randomized in four arms with placebo or TZP at the dose of 5mg,10 mg or 15 mg (72)

Tirzepatide functions by emulating certain hormones that signal satiety

Once approved, retatrutide will likely be prescribed to people with obesity who have not responded well to existing GLP 1 medications

FDA approval of tirzepatide for weight loss At the ADA conference, investigators also confirmed when they expect the FDA to green-light tirzepatide specifically as a weight loss agent regardless of diabetes status